» Articles » PMID: 33586344

Changing Trends in the Disease Burden of Esophageal Cancer in China from 1990 to 2017 and Its Predicted Level in 25 Years

Overview
Journal Cancer Med
Specialty Oncology
Date 2021 Feb 15
PMID 33586344
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nearly half of the cases of esophageal cancer in the world were in China, but the corresponding burden in China has not been estimated for the past decades or for the near future.

Methods: Data on the incidence, mortality, and disability-adjusted life years (DALYs) rates owing to esophageal cancer in China from 1990 to 2017 were extracted from the Global Burden of Disease Study 2017. To reflect the trend in the disease burden, we calculated the estimated annual percentage change (EAPC) in the age-standardized rates of these three outcomes in China from 1990 to 2017.

Results: The age-standardized incidence rate (ASIR) for esophageal cancer decreased from 19.38/100,000 in 1990 to 12.23/100,000 in 2017, with an EAPC of -2.53 (95%CI: -2.90, -2.16), but the number of cases of esophageal cancer increased from 164,473 to 234,624. The age-standardized rates of esophageal cancer in females were always lower than they were in males during the study period, and there was a downward trend that was more pronounced among females than males. The most common risk factors for males were smoking and alcohol consumption, while the most common risk factors for females were a diet low in fruits and a high body mass index (BMI). New cases of, and deaths from esophageal cancer are predicted to increase by about 1.5 times in the coming 25 years.

Conclusion: Although the age-standardized burden of esophageal cancer has been declining, the number of new cases of, and deaths from esophageal cancer have increased in China over the past 30 years, and they will continue to increase in the near future. Hence, national policies should be adopted to promote the prevention and management of known risk factors for it, especially smoking and excessive caloric intake.

Citing Articles

Exploratory analyses of the associations between Ki-67 expression, lymph node metastasis, and prognosis in patients with esophageal squamous cell cancer.

Zheng J, Huang B, Chen Y, Zeng B, Xiao L, Wu M PeerJ. 2025; 13:e19062.

PMID: 40028218 PMC: 11871893. DOI: 10.7717/peerj.19062.


Blood trace elements in association with esophageal squamous cell carcinoma risk, aggressiveness and prognosis in a high incidence region of China.

Qiu S, Xie B, Liao J, Luo J, Liu X, He L Sci Rep. 2025; 15(1):5208.

PMID: 39939385 PMC: 11822019. DOI: 10.1038/s41598-025-89060-7.


SUMO modified ETV1 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by facilitating CCL2 transcription in esophageal squamous cell carcinoma cells.

Han T, Guo X, Xie J, Tong W, Zhang L Cancer Immunol Immunother. 2025; 74(3):87.

PMID: 39891717 PMC: 11787107. DOI: 10.1007/s00262-024-03914-z.


Global regional and national burden of intracerebral hemorrhage between 1990 and 2021.

Wang Z, Wan M, Tai J, Wang Y, Yin M Sci Rep. 2025; 15(1):3624.

PMID: 39880918 PMC: 11779937. DOI: 10.1038/s41598-025-88017-0.


Global, regional, and national burden of esophageal cancer using the 2019 global burden of disease study.

Sun L, Zhao K, Liu X, Meng X Sci Rep. 2025; 15(1):3284.

PMID: 39865149 PMC: 11770103. DOI: 10.1038/s41598-025-86244-z.


References
1.
Sun X, Liu Z, Liu S, Li B, Dai D, Quan P . [Descriptive analysis of incidence and time trends of esophageal and gastric cancers in Linzhou city]. Zhonghua Zhong Liu Za Zhi. 2008; 29(10):764-7. View

2.
Brown L, Hoover R, Silverman D, Baris D, Hayes R, Swanson G . Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol. 2001; 153(2):114-22. DOI: 10.1093/aje/153.2.114. View

3.
Danaei G, Vander Hoorn S, Lopez A, Murray C, Ezzati M . Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet. 2005; 366(9499):1784-93. DOI: 10.1016/S0140-6736(05)67725-2. View

4.
Wang M, Luo X, Xu S, Liu W, Ding F, Zhang X . Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013. Lancet Respir Med. 2018; 7(1):35-45. DOI: 10.1016/S2213-2600(18)30432-6. View

5.
He Z, Liu Z, Liu M, Guo C, Xu R, Li F . Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial. Gut. 2018; 68(2):198-206. DOI: 10.1136/gutjnl-2017-315520. View